All Posts: cancer research
-
Georgetown Breast Cancer Researcher Inducted as AAAS Fellow
(February 15, 2020) — For a career aimed at decoding the biggest challenge in treating the most common cancer in women, the Council of the American Association for the Advancement of Science (AAAS) inducted Georgetown’s Robert Clarke, PhD, DSc, as an AAAS Fellow. The Council elects Fellows annually to honor scientists whose “efforts on behalf […]
Category: Lombardi Stories
-
Hyundai Hands on Hope Contest Again to Raise Money for Pediatric Cancer Research at Georgetown Lombardi
(January 24, 2020) — Georgetown Lombardi has teamed up once again with the Washington Area Hyundai Dealers at the Washington Auto Show to help raise money for pediatric cancer research through the Hyundai Hands On Hope Contest. The contest requires participants to remain in constant contact with a Hyundai vehicle over two days (with a […]
Category: Lombardi Stories
-
Gut Bacteria May Be One Culprit for Increase of Colorectal Cancer in Younger People
SAN FRANCISCO (January 21, 2020) — A bacteria typically linked to periodontal disease, Fusobacterium nucleatum (F. nuc), could play an important role in the rising incidence of colorectal cancer in people under the age of 45. Another type of bacteria, Moraxella osloensis, has been found in colorectal cancer tumors at a nearly four-fold higher rate […]
Category: News Release
-
New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
WASHINGTON (January 21, 2020) — Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance. The study by Georgetown Lombardi Comprehensive Cancer Center researchers appeared […]
Category: News Release
-
Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice
WASHINGTON (December 30, 2019) — Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast […]
Category: News Release
-
Georgetown Lombardi Comprehensive Cancer Center and Hackensack Meridian Health Join New York Genome Center as Associate Members
EDISON, N.J., (December 19, 2019) — The Georgetown Lombardi Comprehensive Cancer Center consortium and Hackensack Meridian Health have become the newest institutional associate members of the New York Genome Center (NYGC), an independent and non-profit academic research institution focused on furthering genomic research. The two institutions join through two separate partnerships using advanced DNA analysis to […]
Category: News Release
-
Palbociclib is Safe for Women with Advanced Breast Cancer Who Have Unique Gene Alteration
WASHINGTON (December 11, 2019) — Women who receive palbociclib (Ibrance®) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN) can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi […]
Category: News Release
-
Scientific Presentations at 2019 Ruesch Symposium Inspire
(December 9, 2019) — Some of the brightest minds in gastrointestinal (GI) cancer from around the country gathered for the scientific session of the 10th-annual Ruesch Symposium at the Omnishore Hotel in Washington, DC. With a packed agenda, the daylong event on December 6 brought together clinicians, researchers, patients, caregivers, policymakers and representatives from industry for […]
Category: Lombardi Stories
-
Remission of Follicular Lymphoma for Two-Plus Years Indicates Disease-Free Status that Could Be Lifelong
Use of next-generation sequencing provides evidence of no detectable lymphoma in these patients. Media Contact Karen Teberkm463@georgetown.edu ATLANTA (December 8, 2019) — People with f
Category: News Release
-
Georgetown’s Aykut Üren Named National Academy of Inventors Fellow
Media Contact Karen Teberkm463@georgetown.edu WASHINGTON (December 3, 2019) — The National Academy of Inventors (NAI) has named Georgetown oncology researcher and educator Aykut Üren, MD, to
Category: News Release